GB9801363D0 - Novel dosage form - Google Patents

Novel dosage form

Info

Publication number: GB9801363D0
Authority: GB; United Kingdom
Prior art keywords: dosage form; novel dosage; novel; dosage
Prior art date: 1998-01-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9801363.4A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kyowa Kirin Services Ltd

Original Assignee

Danbiosyst UK Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-22

Filing date

1998-01-22

Publication date

1998-03-18

1998-01-22 Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd

1998-01-22 Priority to GBGB9801363.4A priority Critical patent/GB9801363D0/en

1998-03-18 Publication of GB9801363D0 publication Critical patent/GB9801363D0/en

1999-01-20 Priority to PCT/GB1999/000193 priority patent/WO1999037290A1/en

1999-01-20 Priority to CA002318257A priority patent/CA2318257A1/en

1999-01-20 Priority to EP99901758A priority patent/EP1059918A1/en

1999-01-20 Priority to AU21760/99A priority patent/AU2176099A/en

1999-01-20 Priority to JP2000528272A priority patent/JP2002501016A/en

1999-01-21 Priority to ZA9900454A priority patent/ZA99454B/en

1999-01-22 Priority to ARP990100264A priority patent/AR014467A1/en

2000-07-14 Priority to NO20003640A priority patent/NO20003640L/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

GBGB9801363.4A 1998-01-22 1998-01-22 Novel dosage form Ceased GB9801363D0 (en)

Priority Applications (9)

Application Number	Priority Date	Filing Date	Title
GBGB9801363.4A GB9801363D0 (en)	1998-01-22	1998-01-22	Novel dosage form
PCT/GB1999/000193 WO1999037290A1 (en)	1998-01-22	1999-01-20	Novel dosage form
CA002318257A CA2318257A1 (en)	1998-01-22	1999-01-20	Novel dosage form
EP99901758A EP1059918A1 (en)	1998-01-22	1999-01-20	Novel dosage form
AU21760/99A AU2176099A (en)	1998-01-22	1999-01-20	Novel dosage form
JP2000528272A JP2002501016A (en)	1998-01-22	1999-01-20	New dosage form
ZA9900454A ZA99454B (en)	1998-01-22	1999-01-21	Novel dosage form.
ARP990100264A AR014467A1 (en)	1998-01-22	1999-01-22	ORMALLY ADMINISTRABLE PHARMACEUTICAL DOSE UNIT OF A SIZE HIGHER THAN 7 MM THAT INCLUDES A DRUG AND EXTERNAL COATING, A METHOD TO PARASEPAR AN ORALLY ADMINISTRABLE PHARMACEUTICAL DOSE UNIT FROM A DIFFERENT CO-ADMINISTRATED FOOD AND USE COVER
NO20003640A NO20003640L (en)	1998-01-22	2000-07-14	New dosage form

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9801363.4A GB9801363D0 (en)	1998-01-22	1998-01-22	Novel dosage form

Publications (1)

Publication Number	Publication Date
GB9801363D0 true GB9801363D0 (en)	1998-03-18

Family

ID=10825713

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9801363.4A Ceased GB9801363D0 (en)	1998-01-22	1998-01-22	Novel dosage form

Country Status (9)

Country	Link
EP (1)	EP1059918A1 (en)
JP (1)	JP2002501016A (en)
AR (1)	AR014467A1 (en)
AU (1)	AU2176099A (en)
CA (1)	CA2318257A1 (en)
GB (1)	GB9801363D0 (en)
NO (1)	NO20003640L (en)
WO (1)	WO1999037290A1 (en)
ZA (1)	ZA99454B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9910773D0 (en) *	1999-05-11	1999-07-07	West Pharm Serv Drug Res Ltd	Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0102342D0 (en) *	2001-01-30	2001-03-14	Smithkline Beecham Plc	Pharmaceutical formulation
WO2006020009A1 (en) *	2004-07-23	2006-02-23	The Procter & Gamble Company	Solid oral dosage form of a bisphosphonate containing a chelating agent
US8912908B2 (en)	2005-04-28	2014-12-16	Proteus Digital Health, Inc.	Communication system with remote activation
US8836513B2 (en)	2006-04-28	2014-09-16	Proteus Digital Health, Inc.	Communication system incorporated in an ingestible product
EP2671507A3 (en)	2005-04-28	2014-02-19	Proteus Digital Health, Inc.	Pharma-informatics system
US8802183B2 (en)	2005-04-28	2014-08-12	Proteus Digital Health, Inc.	Communication system with enhanced partial power source and method of manufacturing same
US9198608B2 (en)	2005-04-28	2015-12-01	Proteus Digital Health, Inc.	Communication system incorporated in a container
CN101496042A (en)	2006-05-02	2009-07-29	普罗秋斯生物医学公司	Patient-tailored treatment protocols
MY158019A (en)	2006-10-25	2016-08-30	Proteus Digital Health Inc	Controlled activation ingestible identifier
US8718193B2 (en)	2006-11-20	2014-05-06	Proteus Digital Health, Inc.	Active signal processing personal health signal receivers
MY165532A (en)	2007-02-01	2018-04-02	Proteus Digital Health Inc	Ingestible event marker systems
JP5614991B2 (en)	2007-02-14	2014-10-29	プロテウスデジタルヘルス，インコーポレイテッド	Internal power supply with large surface area electrode
WO2008112577A1 (en)	2007-03-09	2008-09-18	Proteus Biomedical, Inc.	In-body device having a multi-directional transmitter
WO2008112578A1 (en)	2007-03-09	2008-09-18	Proteus Biomedical, Inc.	In-body device having a deployable antenna
US8540632B2 (en)	2007-05-24	2013-09-24	Proteus Digital Health, Inc.	Low profile antenna for in body device
FI2192946T3 (en)	2007-09-25	2022-11-30		In-body device with virtual dipole signal amplification
MY154699A (en)	2007-11-27	2015-07-15	Proteus Digital Health Inc	Transbody communication systems employing communication channels
EP2268261B1 (en)	2008-03-05	2017-05-10	Proteus Digital Health, Inc.	Multi-mode communication ingestible event markers and systems, and methods of using the same
SG10201702853UA (en)	2008-07-08	2017-06-29	Proteus Digital Health Inc	Ingestible event marker data framework
CA2734251A1 (en)	2008-08-13	2010-02-18	Proteus Biomedical, Inc.	Ingestible circuitry
KR20110103446A (en)	2009-01-06	2011-09-20	프로테우스 바이오메디컬, 인코포레이티드	Intake-Related Biofeedback and Individualized Medical Treatment Methods and Systems
US8540664B2 (en)	2009-03-25	2013-09-24	Proteus Digital Health, Inc.	Probablistic pharmacokinetic and pharmacodynamic modeling
US8545402B2 (en)	2009-04-28	2013-10-01	Proteus Digital Health, Inc.	Highly reliable ingestible event markers and methods for using the same
WO2010132331A2 (en)	2009-05-12	2010-11-18	Proteus Biomedical, Inc.	Ingestible event markers comprising an ingestible component
TWI517050B (en)	2009-11-04	2016-01-11	普羅托斯數位健康公司	System for supply chain management
SG184494A1 (en)	2010-04-07	2012-11-29	Proteus Biomedical Inc	Miniature ingestible device
TWI557672B (en)	2010-05-19	2016-11-11	波提亞斯數位康健公司	Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
WO2012071280A2 (en)	2010-11-22	2012-05-31	Proteus Biomedical, Inc.	Ingestible device with pharmaceutical product
WO2015112603A1 (en)	2014-01-21	2015-07-30	Proteus Digital Health, Inc.	Masticable ingestible product and communication system therefor
US9756874B2 (en)	2011-07-11	2017-09-12	Proteus Digital Health, Inc.	Masticable ingestible product and communication system therefor
US20140203950A1 (en)	2011-07-21	2014-07-24	Mark Zdeblick	Mobile Communication Device, System, and Method
US9235683B2 (en)	2011-11-09	2016-01-12	Proteus Digital Health, Inc.	Apparatus, system, and method for managing adherence to a regimen
CA2897198A1 (en)	2012-07-23	2014-01-30	Proteus Digital Health, Inc.	Techniques for manufacturing ingestible event markers comprising an ingestible component
KR101565013B1 (en)	2012-10-18	2015-11-02	프로테우스 디지털 헬스, 인코포레이티드	Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
WO2014120669A1 (en)	2013-01-29	2014-08-07	Proteus Digital Health, Inc.	Highly-swellable polymeric films and compositions comprising the same
WO2014197402A1 (en)	2013-06-04	2014-12-11	Proteus Digital Health, Inc.	System, apparatus and methods for data collection and assessing outcomes
US10175376B2 (en)	2013-03-15	2019-01-08	Proteus Digital Health, Inc.	Metal detector apparatus, system, and method
US9796576B2 (en)	2013-08-30	2017-10-24	Proteus Digital Health, Inc.	Container with electronically controlled interlock
US10084880B2 (en)	2013-11-04	2018-09-25	Proteus Digital Health, Inc.	Social media networking based on physiologic information
US11051543B2 (en)	2015-07-21	2021-07-06	Otsuka Pharmaceutical Co. Ltd.	Alginate on adhesive bilayer laminate film
TWI775409B (en)	2016-07-22	2022-08-21	日商大塚製藥股份有限公司	Electromagnetic sensing and detection of ingestible event markers
US10820831B2 (en)	2016-10-26	2020-11-03	Proteus Digital Health, Inc.	Methods for manufacturing capsules with ingestible event markers
US11458104B1 (en) *	2018-06-21	2022-10-04	Mission Pharmacal Company	Enteric coated tiopronin tablet
CN109453166B (en) *	2018-10-16	2021-03-12	丹诺医药(苏州）有限公司	Solid dispersion of rifamycin-quinolizinone coupled molecules and application thereof
CN110613697A (en) *	2019-10-30	2019-12-27	长春迪瑞制药有限公司	Cefalexin capsule and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4786508A (en) *	1986-05-30	1988-11-22	Warner-Lambert Company	Coated dosage forms
FR2618331B1 (en) *	1987-07-23	1991-10-04	Synthelabo	PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF UREMIA
NZ228557A (en) *	1988-04-05	1990-11-27	Kyowa Hakko Kogyo Kk	Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions

1998
- 1998-01-22 GB GBGB9801363.4A patent/GB9801363D0/en not_active Ceased
1999
- 1999-01-20 CA CA002318257A patent/CA2318257A1/en not_active Abandoned
- 1999-01-20 JP JP2000528272A patent/JP2002501016A/en active Pending
- 1999-01-20 WO PCT/GB1999/000193 patent/WO1999037290A1/en not_active Application Discontinuation
- 1999-01-20 AU AU21760/99A patent/AU2176099A/en not_active Abandoned
- 1999-01-20 EP EP99901758A patent/EP1059918A1/en not_active Withdrawn
- 1999-01-21 ZA ZA9900454A patent/ZA99454B/en unknown
- 1999-01-22 AR ARP990100264A patent/AR014467A1/en unknown
2000
- 2000-07-14 NO NO20003640A patent/NO20003640L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2176099A (en)	1999-08-09
EP1059918A1 (en)	2000-12-20
CA2318257A1 (en)	1999-07-29
NO20003640L (en)	2000-09-12
JP2002501016A (en)	2002-01-15
AR014467A1 (en)	2001-02-28
WO1999037290A1 (en)	1999-07-29
ZA99454B (en)	2000-10-23
NO20003640D0 (en)	2000-07-14

Publication	Publication Date	Title
GB9801363D0 (en)	1998-03-18	Novel dosage form
GB9817118D0 (en)	1998-10-07	Pharmaceutical compounds
PL341642A1 (en)	2001-04-23	Novel macrolydes
GB9817623D0 (en)	1998-10-07	Pharmaceutical compounds
PL343627A1 (en)	2001-08-27	Medicinal compositions
IL130022A0 (en)	2000-02-29	Nefazodone dosage form
GB9810886D0 (en)	1998-07-22	Pharmaceutical compounds
PT1466615E (en)	2009-09-07	Pharmaceutical composition
PL343769A1 (en)	2001-09-10	Pharmaceutical composition
GB9818591D0 (en)	1998-10-21	Pharmaceutical composition
EP1068213A4 (en)	2001-05-02	Novel aminoorganofunctionalsiloxanes
GB9800750D0 (en)	1998-03-11	Pharmaceutical compound
GB9823847D0 (en)	1998-12-23	Pharmaceutical compounds
GB9823845D0 (en)	1998-12-23	Pharmaceutical compounds
GB9808665D0 (en)	1998-06-24	Therapeutic compounds
PL338781A1 (en)	2000-11-20	Dosage form
GB9824897D0 (en)	1999-01-06	Therapeutic compounds
GB9817197D0 (en)	1998-10-07	Pharmaceutical compounds
GB9827865D0 (en)	1999-02-10	Medicament
TW407677U (en)	2000-10-01	Form
HU9800078D0 (en)	1998-04-28	Pharmaceutical composition
GB9718683D0 (en)	1997-11-05	Novel dosage form
GB9808667D0 (en)	1998-06-24	Therapeutic compounds
ZA989425B (en)	1999-07-28	Dosage form
GB9821694D0 (en)	1998-12-02	Amphiphilogel dosage form

Legal Events

Date	Code	Title	Description
1999-04-14	AT	Applications terminated before publication under section 16(1)